Galicaftor
Idiopathic Pulmonary Fibrosis
Clinical trials
2
Developer
AbbVie
Overview
Galicaftor is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.
Galicaftor clinical trials
Explore related
Medical disclaimer. This page summarizes research about Galicaftor for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.